rubidium has been researched along with dihydroalprenolol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mauger, JP; Worcel, M | 1 |
Bannet, J; Belmaker, RH; Ebstein, RP; Hershkowitz, M | 1 |
2 other study(ies) available for rubidium and dihydroalprenolol
Article | Year |
---|---|
Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Cell Line; Cell Membrane; Dihydroalprenolol; Membranes; Muscles; Radioisotopes; Receptors, Adrenergic; Receptors, Adrenergic, beta; Rubidium | 1980 |
Chronic rubidium does not prevent dopamine receptor supersensitivity.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Dihydroalprenolol; Haloperidol; Mice; Mice, Inbred C3H; Muridae; Receptors, Adrenergic, beta; Receptors, Dopamine; Rubidium; Spiperone | 1982 |